Task: Answer the multiple-choice question.
Query: Which drug exhibits a -0.262% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a. CCOc1ccc2nc(SCC(=O)NC3CCCCC3)[nH]c2c1
b. CCOC(=O)N1CCN(Cc2nc3c(c(=O)n(C)c(=O)n3C)n2Cc2ccccc2C)CC1
c. Cc1cccc(-n2cc(CN3CCN(C(=O)c4ncn[nH]4)CC3)c(-c3cccc(F)c3)n2)c1
Answer: a. CCOc1ccc2nc(SCC(=O)NC3CCCCC3)[nH]c2c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOc1ccc2nc(SCC(=O)NC3CCCCC3)[nH]c2c1
CCOc1ccc2nc(SCC(=O)NC3CCCCC3)[nH]c2c1
N-cyclohexyl-2-[(6-ethoxy-1H-benzimidazol-2-yl)sulfanyl]acetamide